...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Deja Vu All Over Again
12
Mar 10, 2022 02:05PM
5
Mar 10, 2022 02:45PM
4
Mar 10, 2022 03:08PM
3
Mar 10, 2022 03:19PM
1
Mar 10, 2022 03:30PM
2
Mar 10, 2022 07:00PM
10
Mar 11, 2022 03:19PM
3
Mar 11, 2022 04:57PM
7
Mar 11, 2022 05:28PM
7
Mar 11, 2022 05:35PM

I believe that the majority of the trial will be focused in Brazil. Getting the unvaccinated to enter the trial in North America would be an exercise in futility. 

Koo, why can't we get the vaccinated in Edmonton and Calgary to take apabetalone? News to me that it has to be the unvaccinated...and there sure were enough of both who got Omicron. Please somebody show me where this was only intended for the unvaxxed! Or is this an assumption because Don keeps using them as an excuse?

Furthermore, it begs the question if BP has the clout to even kill the enthusiasm of doctors on the Covid ward when it comes to selling the patients on our little wonder drug? We all remember how long this was stalled since early 2021, when Don thought we could even start dosing last March.

Here's the criteria again:

https://clinicaltrials.gov/ct2/show/NCT04894266?spons=resverlogix&draw=2&rank=1

2
Mar 11, 2022 07:38PM
9
Mar 11, 2022 08:47PM
6
Mar 12, 2022 02:20AM
6
Mar 12, 2022 10:10AM
10
Mar 12, 2022 11:40AM
3
Mar 12, 2022 08:50PM
1
Mar 12, 2022 08:52PM
5
Mar 12, 2022 08:56PM
9
Mar 12, 2022 11:20PM
1
Mar 13, 2022 09:51AM
5
Mar 13, 2022 10:47AM
6
Mar 13, 2022 12:56PM
2
Mar 13, 2022 08:12PM
Share
New Message
Please login to post a reply